The Roles of CCR9/CCL25 in Inflammation and Inflammation-Associated Diseases
Open Access
- 19 August 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9
Abstract
Chemokine is a structure-related protein with a relatively small molecular weight, which can target cells to chemotaxis and promote inflammatory response. Inflammation plays an important role in aging. C-C chemokine receptor 9 (CCR9) and its ligand C-C chemokine ligand 25 (CCL25) are involved in the regulating the occurrence and development of various diseases, which has become a research hotspot. Early research analysis of CCR9-deficient mouse models also confirmed various physiological functions of this chemokine in inflammatory responses. Moreover, CCR9/CCL25 has been shown to play an important role in a variety of inflammation-related diseases, such as cardiovascular disease (CVD), rheumatoid arthritis, hepatitis, inflammatory bowel disease, asthma, etc. Therefore, the purpose of this review gives an overview of the recent advances in understanding the roles of CCR9/CCL25 in inflammation and inflammation-associated diseases, which will contribute to the design of future experimental studies on the potential of CCR9/CCL25 and advance the research of CCR9/CCL25 as pharmacological inflammatory targets.Keywords
This publication has 93 references indexed in Scilit:
- The Chemokine Superfamily RevisitedImmunity, 2012
- Plasmacytoid Dendritic Cells Transport Peripheral Antigens to the Thymus to Promote Central ToleranceImmunity, 2012
- Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratiosGut, 2012
- The Chemokine Receptor CCR9 Is Required for the T-Cell–Mediated Regulation of Chronic Ileitis in MiceGastroenterology, 2011
- Necrotizing EnterocolitisNew England Journal of Medicine, 2011
- Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiationArthritis Research & Therapy, 2010
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsAnnals of the Rheumatic Diseases, 2010
- Differential homing mechanisms regulate regionalized effector CD8αβ + T cell accumulation within the small intestineProceedings of the National Academy of Sciences, 2007
- Homeostatically proliferating CD4+ T cells are involved in the pathogenesis of an Omenn syndrome murine modelJournal of Clinical Investigation, 2007
- CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestineProceedings of the National Academy of Sciences, 2007